HemoShear Therapeutics is a biotechnology company focused on discovering novel biological targets and developing drugs to treat children’s rare metabolic disorders. Our goal is to discover drugs that save the lives of children who are born with metabolic defects and are unable to sustain basic biochemical processes necessary for life. Our proprietary technology allows us to recapitulate diseases using tissue from livers of children born with genetic defects, interrogate the disrupted biochemical processes, explore drug intervention strategies, and select drug candidates that we believe have high probabilities of clinical success. HemoShear is markedly different from other biotechnology companies because of our proprietary human disease models and our ability to recreate and interpret complex human biology. We believe that no other company can match our ability to understand human hepatic, tumor, or vascular disease biology and translate those findings into discovery of safe and effective drug treatments. We are passionate about understanding disease biology and driven to discover drug treatments that improve health outcomes and save lives. For more information, see www.hemoshear.com.
View Top Employees from HemoShear TherapeuticsWebsite | http://www.hemoshear.com |
Revenue | $6 million |
Funding | $52.5 million |
Employees | 50 (50 on RocketReach) |
Founded | 2008 |
Address | 501 Locust Ave Suite 301, Charlottesville, Virginia 22902, US |
Phone | (434) 872-0196 |
Fax | (434) 872-0199 |
Technologies |
HTML,
PHP,
Google Analytics
+7 more
(view full list)
|
Industry | Biotechnology Research, Education General, Biotechnology, Drug Discovery & Development, Education, Science and Engineering, Rare Metabolic Diseases, Health Care, Human Disease Research, Medical, NASH |
Competitors | Acumen Pharmaceuticals, Inc., Angiochem, Circuit Therapeutics, OxThera, Patrys Limited |
SIC | SIC Code 8733 Companies, SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular HemoShear Therapeutics employee's phone or email?
The HemoShear Therapeutics annual revenue was $6 million in 2024.
Aric Holsinger is the CFO of HemoShear Therapeutics.
50 people are employed at HemoShear Therapeutics.
HemoShear Therapeutics is based in Charlottesville, Virginia.
The NAICS codes for HemoShear Therapeutics are [541, 54171, 541714, 5417, 54].
The SIC codes for HemoShear Therapeutics are [8733, 87, 873].